MOnitoring psychoPHARmacology (MOPHAR)

Sample details

MOPHAR is an infrastructure for implementation of standardised routine outcome monitoring of objective somatic adverse effects including metabolic disturbances, as well as subjective symptoms of psychiatric pharmacotherapy and medication reconciliation in outpatients. The cohort is prospective and naturalistic, in which all patients with a bipolar, mood, or anxiety disorder are invited to participate in a measurement at the outpatient clinics of Mental Health Services (MHS; in Dutch: GGZ) Drenthe and after one year. Patients within the cohort are 18 years or older and have visited the participating outpatient department for the first time after January 1st, 2010.

Study design
Cohort - clinical, Cohort - open, Cohort - research programme

Number of participants at first data collection

> 3000 (participants)

Recruitment is ongoing

Age at first data collection

≥ 18 years (participants)

Participant year of birth

Varied (participants)

Participant sex
All

Representative sample at baseline?
No

Sample features

Patients and clinical populations

People with psychiatric conditions

Dataset details

Country

Netherlands

Year of first data collection

2016

Primary Institutions

GGZ Drenthe

Links

ggzdrenthe.nl/onderzoek-mophar

umcgresearchdatacatalogue.nl/UMCG/catalogue/all/collections/MindLines/subpopulations/MOPHAR

doi.org/10.1186/s12888-023-05022-1

Profile paper DOI

doi.org/10.1186/s12913-019-3951-2

Funders

Mental Health Services Drenthe

Ongoing?
Yes

Data types collected

Quantitative data collection

Computer, paper or task testing (e.g. cognitive testing, theory of mind doll task, attention computer tasks)
Interview – face-to-face
Physical or biological assessment (e.g. blood, saliva, gait, grip strength, anthropometry)
Self-report questionnaire – online

Qualitative data collection